A detailed history of Kennedy Capital Management, Inc. transactions in Chimerix Inc stock. As of the latest transaction made, Kennedy Capital Management, Inc. holds 153,620 shares of CMRX stock, worth $138,258. This represents 0.0% of its overall portfolio holdings.

Number of Shares
153,620
Previous 135,220 13.61%
Holding current value
$138,258
Previous $118,000 20.34%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$0.77 - $1.07 $14,168 - $19,688
18,400 Added 13.61%
153,620 $142,000
Q2 2024

Aug 14, 2024

BUY
$0.87 - $1.05 $117,641 - $141,981
135,220 New
135,220 $118,000

Others Institutions Holding CMRX

About CHIMERIX INC


  • Ticker CMRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,622,896
  • Market Cap $78.9M
  • Description
  • Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs i...
More about CMRX
Track This Portfolio

Track Kennedy Capital Management, Inc. Portfolio

Follow Kennedy Capital Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kennedy Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Kennedy Capital Management, Inc. with notifications on news.